BioNTech SE - ADR vs Marriott International Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Marriott International Inc trades at $349.88 (market cap $91.14B). The key difference: Marriott International Inc is far larger — about 3.9× BioNTech SE - ADR's market cap, and Marriott International Inc pays a 0.84% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | MAR | |
|---|---|---|
Market Cap | $23.31B | $91.14B |
Sector | Health | Consumer Cyclical |
52-Week High | $119.34 | $402.54 |
52-Week Low | $83.89 | $259.04 |
Enterprise Value | $6.60B | $108.45B |
Dividend Yield | — | 0.84% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →